---
category: trading
circular_id: 3f3960f109382acc
date: '2025-08-21'
description: Updated settlement calendar for the acquisition window takeover offer
  for PHARMAIDS PHARMACEUTICALS LIMITED with revised obligation download and settlement
  dates.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9242081B-5F9C-4544-802E-04E72A83397D}&noticeno=20250821-1&dt=08/21/2025&icount=1&totcount=73&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Affects specific takeover settlement timeline for one company with
  clear compliance requirements
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250821-1&attachedId=
processing:
  attempts: 1
  content_hash: ab66e54d165340ac
  processed_at: '2025-08-21T18:48:19.997154'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-21T06:20:03+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={9242081B-5F9C-4544-802E-04E72A83397D}&noticeno=20250821-1&dt=08/21/2025&icount=1&totcount=73&flag=0
severity: medium
source: bse
stocks:
- PHARMAIDS
tags:
- otb
- revised-schedule
- settlement
- takeover
title: Revised Settlement Schedule for PHARMAIDS PHARMACEUTICALS LIMITED Takeover
  Offer
---

## Summary

BSE has revised the settlement schedule for the Offer to Buy â€“ Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LIMITED. The takeover offer conducted from August 4-18, 2025 now has updated obligation download and settlement dates.

## Key Points

- Settlement No: 2025067
- Bid Period: August 4, 2025 to August 18, 2025
- Revised Obligation Download Date: August 22, 2025
- Revised Settlement Date: August 25, 2025
- Demat shares must be delivered through Early Pay-in mechanism only
- Market Type "Takeover" and settlement No. 2025035 to be used in depository system

## Regulatory Changes

No new regulatory changes - this is an administrative revision to previously announced takeover settlement schedule.

## Compliance Requirements

- Members/Custodians must use Early Pay-in of Shares mechanism for demat share delivery
- Must specify Market Type "Takeover" and correct settlement number in depository system
- Refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges
- Follow revised guidelines for share acquisition through stock exchange

## Important Dates

- **August 22, 2025**: Revised Obligation Download Date
- **August 25, 2025**: Revised Settlement Date
- Bid period already completed: August 4-18, 2025

## Impact Assessment

Limited impact as this affects only participants in the PHARMAIDS PHARMACEUTICALS takeover offer. The revision provides additional time for settlement processing and ensures proper completion of the acquisition window process.